ADAR1 Capital Management, LLC, 10% Owner at InMed Pharmaceuticals Inc. (INM), bought 91,101 shares at $1.29 ($118K) on 2026-09-14, disclosed to the SEC on 2026-09-16.
Open-market purchase of $118k INM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.29 | 28,505 | $37K | 31.2% |
| 2 | $1.30 | 54,256 | $70K | 59.7% |
| 3 | $1.29 | 8,340 | $11K | 9.1% |
| Total | $1.30 avg | 91,101 | $118K | 100% |
| Filing → |
| INM | BUY | 2026-10-05 | $57K | — | Filing → |
| TENX | BUY | 2026-09-08 | $1.6M | — | Filing → |
| TENX | BUY | 2026-09-02 | $1.4M | — | Filing → |